Consequently, we analyzed single-cell sequencing datasets derived from patients with MM, which revealed a considerable downregulation in BCMA expression in tumor specimens from individuals with relapsed MM following BCMA-targeted CAR-T cell treatment, as shown in Fig. 1c. Here, TNFRSF17 is linked to neoplasm.